• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDOS INTERNATIONAL SàRL CH UNKNOWN CAGE/SPACER; INTERVERTEBRAL FUSION DEVICE W/INTEGRATED FIXATION,LUMBAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDOS INTERNATIONAL SàRL CH UNKNOWN CAGE/SPACER; INTERVERTEBRAL FUSION DEVICE W/INTEGRATED FIXATION,LUMBAR Back to Search Results
Catalog Number UNK CAGE/SPACER
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Ossification (1428); Dysphagia/ Odynophagia (1815); Osteolysis (2377)
Event Type  Injury  
Manufacturer Narrative
Product complaint (b)(4).This report is for an unknown cage/spacer/unknown lot.Part and lot numbers are unknown; udi number is unknown.Complainant part is not expected to be returned for manufacturer review/investigation.Investigation summary: product was not returned.Based on the information available, it has been determined that no corrective and preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event Description
This report is being filed after the review of the following journal article: pourtaheri s, et al.(2013), cervical corpectomy with ultra-low-dose rhbmp-2 in high-risk patients: 5-year outcomes, orthopedics, volume 36, number 12, pages 931-935, (usa).This study evaluated the clinical and radiographic outcomes of using 0.26 to 0.35 mg/ml of rhbmp-2 in cervical corpectomies in patients who were considered high risk for pseudarthrosis (tobacco smokers and patients with diabetes mellitus).Between august 2007 and december 2009, 24 patients who underwent cervical corpectomy with low-dose rh-bmp-2 were included in the study.There were 13 men and 11 women with a mean age of 60+/-9 years.All anterior fusions were performed through a smith-robinson approach.The rh- bmp-2 was prepared at a concentration of 0.26 to 0.35 mg per level with local autograft from the corpectomy and demineralized bone matrix in a polyetheretherketone (peek) spacer (unknown depuy spine bengal spacer).All patients received a cervical drain and were intubated at the end of the operation.Postoperatively, a hard collar was worn for 2 weeks, followed by a soft collar for another 2 weeks.6 weeks postoperatively, therapy was initiated.All patients were assessed clinically postoperatively at 2 and 6 weeks, 6 months, 1 year, and then annually.Mean follow-up was 5 years (range, 3.5-6 years).Complications were reported as follows: 14 patients had hoarseness at 2-week follow-up which resolved in all but 2 patients.12 patients had dysphagia (8 mild, 3 moderate, and 1 severe).9 patients continued to have dysphagia at 6 weeks (8 mild, 1 moderate).5 patients had dysphagia at 6 months (5 mild).4 patients had dysphagia at latest follow-up (mean, 4.5 years).10 patients had resorption at 2 weeks.4 patients had developed heterotopic ossification posterior to the graft.4 patients had postoperative adjacent segment degeneration.Only 1 of the patients was symptomatic, and it was addressed with a 1-level anterior cervical fusion without rhbmp-2; symptoms resolved with no dysphagia at 6-week and 2-year follow-up.4 patients had subsidence.None of the cases was symptomatic.This report is for the unknown depuy spine bengal spacer.This report is 2 of 2 for (b)(4).This impacted product captures the following events: hoarseness, dysphagia, resorption, heterotopic ossification, adjacent segment degeneration.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKNOWN CAGE/SPACER
Type of Device
INTERVERTEBRAL FUSION DEVICE W/INTEGRATED FIXATION,LUMBAR
Manufacturer (Section D)
MEDOS INTERNATIONAL SàRL CH
chemin-blanc 38
le locle 02400
SZ  02400
Manufacturer (Section G)
MEDOS INT SPINE
chemin blanc 38
le locle
SZ  
Manufacturer Contact
kara ditty-bovard
chemin-blanc 38
le locle 2400
SZ   2400
MDR Report Key11958018
MDR Text Key254865105
Report Number1526439-2021-01175
Device Sequence Number1
Product Code ODV
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 05/13/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/08/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK CAGE/SPACER
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/13/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-